Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Budesonide in Pediatric Upper GI Crohn's Disease
NCT06719622Phase 3Enrolling by invitation
- Sponsor
- Medical University of Warsaw
- Start
- Jul 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide in Crohn's disease, sponsored by Medical University of Warsaw. Started Jul 2024; status: enrolling by invitation.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06719622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06719622.